Evaluation of Inhaled Treatment in Sinusitis

Evaluation of Inhaled Corticosteroid Treatment in Sinusitis

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 2
  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nasal/Sinus polyps

Exclusion Criteria:

  • Previous sinus surgery
  • Age under 18y
  • Use of antibiotics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Oral
Oral drug (methylprednisolone) administration
Oral 32mg/8d-16mg/4d-8mg/4d
Experimental: Metered dose inhaler
Budesonide by metered dose inhaler
Budesonide by nebulization
Experimental: Nebulized
Budesonide by metered dose inhaler
Budesonide by nebulization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Sniffin' Sticks Test
Time Frame: Baseline and day 15
Baseline and day 15

Secondary Outcome Measures

Outcome Measure
Time Frame
Specific quality of life questionnaire (Snot 20)
Time Frame: Baseline and day 15
Baseline and day 15
Retro Olfaction Test
Time Frame: Baseline and day 15
Baseline and day 15

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Gregory Reychler, PhD, Cliniques universitaires Saint-Luc
  • Study Director: Philippe Rombaux, Prof PhD, Cliniques universitaires Saint-Luc
  • Principal Investigator: Coralie Colbrant, PT, Cliniques universitaires Saint-Luc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

July 12, 2013

First Submitted That Met QC Criteria

July 18, 2013

First Posted (Estimate)

July 24, 2013

Study Record Updates

Last Update Posted (Estimate)

January 27, 2014

Last Update Submitted That Met QC Criteria

January 24, 2014

Last Verified

January 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.